Clik here to view.
Babson Graduate Pooja Ika Launches eternalHealth, the First New Medicare...
BOSTON eternalHealth, the first new health plan to be approved in Massachusetts since 2013, has officially announced its launch of the company, delivering high-quality and affordable Medicare...
View ArticleClik here to view.
アナンダ・サイエンティフィック、オピオイド使用障害（OUD）治療に関する臨床試験のINDをFDAが承認したと発表
米コロラド州グリーンウッドビレッジ & ロサンゼルス （ビジネスワイヤ） — アナンダ・サイエンティフィック（バイオ製薬企業）は本日、アナンダ専有の送達技術に基づくカンナビジオール（CBD）を使用した治験薬であるNantheia™...
View ArticleClik here to view.
阿南达医药科技宣布FDA批准了针对阿片类用药障碍（OUD）的新药临床试验申请
科罗拉多州格林伍德村和洛杉矶 (美国商业资讯)–生物制药公司 阿南达医药科技公司（ANANDA Scientific Inc.）今天宣布 美国食品和 药物管理局（ FDA ）批准了Nantheia™ ATL5临床评估试验的新药研究（IND）申请。Nantheia™ ATL5是一种采用...
View ArticleClik here to view.
Alentis Therapeutics启动旨在治疗肝肾纤维化的首次人体临床试验
瑞士巴塞尔 (美国商业资讯)–Alentis Therapeutics, AG今天宣布，该公司已在ALE.F02首次人体一期临床试验中对第一批健康受试者进行给药。ALE.F02是一种对Claudin-1呈高度选择性的单克隆抗体，目前正用于开发针对无适当医药的晚期肝肾纤维化的疗法。Alentis是一家临床阶段生物制药公司，专注于发现和开发面向无适当医药的纤维化疾病的突破性疗法。...
View ArticleClik here to view.
Myomo Amends China Joint Venture Agreement, Executes Technology and Trademark...
BOSTON Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper...
View ArticleClik here to view.
HighTide Therapeutics Appoints Jin Chen, Ph.D., as SVP DMPK and Clinical...
SHENZHEN, China & ROCKVILLE, Md. HighTide Therapeutics Inc., a clinical-stage biopharmaceutical company developing treatments for liver diseases, gastrointestinal diseases and metabolic...
View ArticleClik here to view.
New Frontier Health Corporation Announces Shareholders’ Approval of Merger...
BEIJING New Frontier Health Corporation (“NFH” or the “Company”) (NYSE: NFH), operator of the premium healthcare services provider United Family Healthcare, today announced that, at an extraordinary...
View ArticleClik here to view.
Pharmaron Appoints Dr. Sid Bhoopathy as Senior Vice President, US Head of...
BEIJING Pharmaron Beijing Co., Limited (Stock Code: 300759.SZ/3759.HK) (“Pharmaron”) today announced the appointment of Dr. Sid Bhoopathy as Senior Vice President, US Head of Laboratory Services and...
View ArticleClik here to view.
Pharmaron Acquires Commercial API Manufacturing Facility in the United...
BEIJING Pharmaron Beijing Co., Limited (Stock Code: 300759.SZ/3759.HK) (“Pharmaron”) announced today that it has acquired Aesica Pharmaceuticals Limited (“The Cramlington Site”) from Recipharm...
View ArticleClik here to view.
Clik here to view.
Aptorum Group Announces Completion of Phase I Clinical Trials for ALS-4 and...
NEW YORK & LONDON & PARIS Regulatory News: Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) (“Aptorum Group” or “Aptorum”), a clinical-stage biopharmaceutical company, announces...
View ArticleClik here to view.
Takeda Emphasizes Strategy for Delivering Sustainable Growth Over Next Decade...
OSAKA, Japan & CAMBRIDGE, Mass. Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today confirmed the company is positioned for growth in the mid- and long-term with the...
View ArticleClik here to view.
The World Must Challenge China’s Attack on Public Health Transparency, Says AHF
LOS ANGELES AIDS Healthcare Foundation (AHF) expressed alarm and disappointment today over China’s reported move to delete language supporting rapid World Health Organization (WHO) access to...
View ArticleClik here to view.
New Frontier Health Corporation Receives Notification from NYSE Regarding...
BEIJING New Frontier Health Corporation (NYSE: NFH) (“NFH” or the “Company”), the operator of the premium healthcare services provider United Family Healthcare, today reported that, on January 4,...
View ArticleClik here to view.
武田在第40届摩根大通医疗健康年会上强调未来十年实现可持续增长的战略
日本大阪和马萨诸塞州剑桥 (美国商业资讯)–武田药品工业株式会社(Takeda Pharmaceutical Company Limited, TSE:4502/NYSE:TAK)（“武田”）今天确认，该公司已做好中长期增长的准备，并有望在2030财年之前实现增量收入增长和额外的上行潜力。在第40届摩根大通医疗健康年会上，武田总裁兼首席执行官Christophe...
View ArticleClik here to view.
リバプールCCGとコミュニティー・ファーマシー・リバプールが100軒以上の地域薬局でFebriDx®サービスを開始
英リバプール （ビジネスワイヤ） — 本日、リバプール・クリニカル・コミッショニング・グループ（CCG）とコミュニティー・ファーマシー・リバプールは、100軒以上の薬局で10分間のポイントオブケア検査を行い、細菌性とウイルス性の呼吸器感染症を判別する新しい臨床サービスを開始しました。...
View ArticleClik here to view.
Liverpool CCG和Community Pharmacy Liverpool在100多家社区药房推出FebriDx®服务
英格兰利物浦 (美国商业资讯)–今天，Liverpool Clinical Commissioning Group (CCG)和Community Pharmacy Liverpool启动了一项新的临床服务，支持100多家药房提供10分钟即时检测服务，以区分细菌性和病毒性呼吸道感染。 本新闻稿包含多媒体。此处查看新闻稿全文：...
View ArticleClik here to view.
Headspace Health宣布收购人工智能心理健康与保健公司Sayana
旧金山 (美国商业资讯)–全球极易获取的综合型数字心理健康平台供应商Headspace Health今天宣布，其已收购人工智能心理健康与保健公司Sayana。Sayana将扩展Headspace Health的能力，帮助Headspace Health为不断增加的全球会员提供个性化的自我护理内容。 本新闻稿包含多媒体。此处查看新闻稿全文：...
View ArticleClik here to view.
BLESSED MOON, Korean Skincare Brand, Expands Into Global Markets With Vitamin...
BUSAN, South Korea BLESSED MOON (CEO: Eun Bin Moon), a popular skincare brand in Korea, expands into overseas markets with its vitamin eye cream ‘Eye Kit’. Consisted of an eye cream ‘Eye Kit’, a...
View ArticleClik here to view.
武田薬品が今後10年に持続可能な成長を達成する戦略を第40回年次J.P.モルガン・ヘルスケア・カンファレンスで強調
大阪 & 米マサチューセッツ州ケンブリッジ （ビジネスワイヤ） —...
View Article